[go: up one dir, main page]

HK1069114A - 应用性类固醇功能调节剂治疗创伤和纤维变性疾病 - Google Patents

应用性类固醇功能调节剂治疗创伤和纤维变性疾病 Download PDF

Info

Publication number
HK1069114A
HK1069114A HK05101888.8A HK05101888A HK1069114A HK 1069114 A HK1069114 A HK 1069114A HK 05101888 A HK05101888 A HK 05101888A HK 1069114 A HK1069114 A HK 1069114A
Authority
HK
Hong Kong
Prior art keywords
wound
oestrogen
fibrosis
group
wounds
Prior art date
Application number
HK05101888.8A
Other languages
English (en)
Inventor
Mark William James Ferguson
Gillian Sarah Ashcroft
Original Assignee
Renovo Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Limited filed Critical Renovo Limited
Publication of HK1069114A publication Critical patent/HK1069114A/zh

Links

HK05101888.8A 1996-07-22 2005-03-04 应用性类固醇功能调节剂治疗创伤和纤维变性疾病 HK1069114A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9615348 1996-07-22
GB9701600 1997-01-27

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
HK00100174.8A Addition HK1021319B (zh) 1996-07-22 1997-07-22 一种化合物之应用以提升雌激素活动来治疗创伤
HK07107548.5A Division HK1100064A (zh) 1996-07-22 2005-03-04 使用性腺类固醇功能调节剂治理创伤及纤维化疾病

Related Child Applications (2)

Application Number Title Priority Date Filing Date
HK00100174.8A Division HK1021319B (zh) 1996-07-22 1997-07-22 一种化合物之应用以提升雌激素活动来治疗创伤
HK07107548.5A Addition HK1100064A (zh) 1996-07-22 2005-03-04 使用性腺类固醇功能调节剂治理创伤及纤维化疾病

Publications (1)

Publication Number Publication Date
HK1069114A true HK1069114A (zh) 2005-05-13

Family

ID=

Similar Documents

Publication Publication Date Title
US6696433B2 (en) Use of sex steroids function modulators to treat wounds and fibrotic disorders
Ashcroft et al. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response
Simoncini et al. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase
US4310523A (en) Combined antiestrogens and antigonadotropically effective antiandrogens for the prophylaxis and therapy of hyperplasia of the prostate
Ashcroft et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels
Pratt et al. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media
Frazier-Jessen et al. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages.
CA2394165C (en) Drospirenone for hormone replacement therapy
EP1003522B1 (en) Use of estrogen for preventing or controlling cataract
EP2078032B1 (en) Compositions and methods for suppressing endometrial proliferation
EP0844884A2 (en) Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
US20060063723A1 (en) Pharmaceutical composition comprising esterol derivatives for use in cancer therapy
JP4579349B2 (ja) 子宮頸の拡大及び拡張度を制御するための酸化窒素供与体及び／又は基質又は酸化窒素インヒビター
AU755438B2 (en) Use of sex steroid function modulators to treat wounds and fibrotic disorders
HK1069114A (zh) 应用性类固醇功能调节剂治疗创伤和纤维变性疾病
HK1100064A (zh) 使用性腺类固醇功能调节剂治理创伤及纤维化疾病
HK1021319B (zh) 一种化合物之应用以提升雌激素活动来治疗创伤
Menchini et al. Epidermolysis bullosa
JPH11501648A (ja) 男性の生殖能を調節するための抗エストロゲンの使用
RS56491B1 (sr) Kompozicije i postupci za supresiju proliferacije endometrijuma
MXPA97008577A (en) Endothelin antagonists and inhibitors of endothelin synthesis for the prevention and treatment of uterine contractility disorders, preeclampsia, vascular aterosclerotic diseases, hypertension and for replacement therapy